Figures & data
Figure 1. Treatment schedule and division of groups for elevated plus-maze paradigm. m, minutes; TL, transfer latency; h, hours; SCO, scopolamine (1 mg/kg, i.p.); FRFE 10, 50, and 100, Ficus religiosa fig extract (10, 50, and 100 mg/kg, i.p.); CYP, cyproheptadine (4 mg/kg, i.p.).
Figure 2. Treatment schedule and division of groups for modified passive avoidance paradigm. m, minutes; SDL, step down latency; NT, number of trials; NM, number of mistakes; h, hours; SCO, scopolamine (1 mg/kg, i.p.); FRFE 10, 50, and 100, Ficus religiosa fig extract (10, 50, and 100 mg/kg, i.p.); CYP, cyproheptadine (4 mg/kg, i.p.).
Figure 3. Effect of FRFE on transfer latency in scopolamine-induced amnesia (before learning). a,a*p < 0.05 as compared to Group I (naive) 1st and 2nd day respectively; b,b*p < 0.05 as compared to Group II (vehicle control) 1st and 2nd day respectively, and c,c*p < 0.05 as compared to Group V (FRFE 100 mg/kg) 1st and 2nd day respectively.
Figure 4. Effect of FRFE on transfer latency in scopolamine-induced amnesia (before retrieval). ap < 0.05 as compared to Group VIII (naive), bp < 0.05 as compared to Group IX (vehicle control), and cp < 0.05 as compared to Group XII (FRFE 100 mg/kg).
Figure 5. Effect of FRFE on number of trials and mistakes in scopolamine-induced amnesia (before learning). a,a*p < 0.05 as compared to Group XV (naive) 1st and 2nd day respectively, b,b*p < 0.05 as compared to Group XVI (vehicle control) 1st and 2nd day respectively, and c,c*p < 0.05 as compared to Group XIX (FRFE 100 mg/kg) 1st and 2nd day respectively.
Figure 6. Effect of FRFE on step down latency in scopolamine-induced amnesia (before retrieval). ap < 0.05 as compared to Group XXII (naive), bp < 0.05 as compared to Group XXIII (vehicle control), and cp < 0.05 as compared to Group XXVI (FRFE 100 mg/kg).
